Latest Articles
-
Year One Progress on Identifying Methodologies for Adherence or Persistence to Oral Anticancer Medications
The quality of oral anticancer medication (OAM) use impacts clinical care, care coordination, patient safety, and outcomes, including disparities in care, patient and caregiver experience, population health, and total health care costs. To monitor the quality of OAM use, measures assessing the degree to which patients take OAMs as prescribed was the number one measurement priority rated by 23 national experts and patients convened by PQA […] -
Five for Friday April 24: Celebrating Success in Advancing Medication Use Quality
PQA was established 20 years ago today! On April 24, 2006, the Centers for Medicare & Medicaid Services (CMS) hosted a special expanded Open Door Forum to publicly announce, support and promote high-value pharmacy services, including measurement approaches, through a stakeholder-led PQA. Since then, PQA’s mission to “optimize health by advancing the quality of medication use” has remained at […] -
PQA Was Established 20 Years Ago Today
The Centers for Medicare & Medicaid Services (CMS) hosted a special expanded Open Door Forum on April 24, 2006, to publicly announce, support and promote high-value pharmacy services, including measurement approaches, through a stakeholder-led Pharmacy Quality Alliance (PQA). In the months leading up to this date, CMS was working with leading pharmacy and health care organizations to create PQA as a collaborative alliance, where key stakeholders would agree on strategies for measuring performance […] -
PQA Appoints 18 Individuals to Serve on Heart Failure TEP
PQA has appointed 18 individuals to serve on a measure development technical expert panel (TEP) to support the development of a new health plan measure: Evidence of Guideline-Directed Medical Therapy in Persons with Heart Failure. This measure will assess the percentage of individuals with prescription claims for guideline-directed medical therapies for the treatment of heart failure. PQA identified heart failure […] -
Enduring Partners in Quality: PQA’s Founding and Original Members
The Pharmacy Quality Alliance was born from a collaboration. In 2006, when Medicare Part D was launched, Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan had a vision to not simply cover seniors’ medication costs, but to pay for high value-care. McClellan’s vision included a public-private partnership – with diverse stakeholders from across health care – that would develop quality measures to help evaluate the Part D program and incentivize plan participants in value-based care. To build the partnership, […] -
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
-
PQA Presents Quality Awards to 10 Medicare Plan Contracts for High Achievement in Medication Quality Measures
Awards Honor Excellence and Improvement in Overall CMS Medicare Part D Star Ratings and PQA Medication Measures Alexandria, Va. (April 14, 2026) – The Pharmacy Quality Alliance (PQA) has recognized 10 Medicare plan contracts with a PQA Laura Cranston Excellence in Quality or Quality Improvement Award for high achievement or significant improvement in PQA measures of […] -
Assessing the Evidence to Support New MTM Quality Measures
When quality measures are used for performance comparisons within national programs, they should meet the measure evaluation criteria of importance, feasibility, scientific acceptability and usability. To satisfy importance criterion, evidence should demonstrate that the process of care meaningfully affects the desired outcome. PQA upholds these established standards for performance measure development, including sufficient evidence of the impact of the process of care on the desired outcome. Researchers at PQA reviewed evidence focusing on the impact on outcomes from the Medicare Part D MTM program or services such as […] -
Five for Friday April 10: Celebrating Success in Advancing Medication Use Quality
The 2026 PQA Annual Meeting is less than six weeks away, and we are excited to welcome you all back to Baltimore to celebrate 20 years of quality. Every speaker for the meeting is confirmed. Our sessions will cover timely topics, including GLP-1s, oncology, pharmacy access, clinical documentation for VBAs, and what’s next for the Star Ratings. […] -
Year One Progress on Identifying Methodologies for Adherence or Persistence to Oral Anticancer Medications
The quality of oral anticancer medication (OAM) use impacts clinical care, care coordination, patient safety, and outcomes, including disparities in care, patient and caregiver experience, population health, and total health care costs. To monitor the quality of OAM use, measures assessing the degree to which patients take OAMs as prescribed was the number one measurement priority rated by 23 national experts and patients convened by PQA […]
PQA In the News
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
-
Pharmacy Quality Alliance Elects 2026 Board of Directors and Executive Committee
-
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality
“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Strategic Media Partnerships
PQA partners with a variety of media to provide news, insights and opinions.
Stay Informed
Get the latest PQA news and events delivered to your inbox.